Lineage Cell Therapeutics (LCTX) Form 5 BIOTIME / ALFRED D KINGSLEY ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

KINGSLEY ALFRED D

(Last) (First) (Middle)

150 E. 57TH STREET

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
BIOTIME INC [ BTX ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
X	Officer (give title below)	Other (specify below)
See Remarks

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2017

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
Common Shares, no par value	10/01/2017(1)		G	10,000	D	(1)	5,471,555(2)	D
Common Shares, no par value	12/01/2017(3)		G	100,000	D	(3)	1,043,346	I	By Greenbelt Corp.
Common Shares, no par value							375,351	I	By Greenway Partners, LP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Option to Purchase Common Shares	$4.13						(4)	06/30/2018	Common Shares	50,000		50,000	D
Option to Purchase Common Shares	$3.11						(5)	06/30/2019	Common Shares	50,000		50,000	D
Option to Purchase Common Shares	$3.57						(6)	06/30/2020	Common Shares	50,000		50,000	D
Option to Purchase Common Shares	$2.72						(7)	06/30/2021	Common Shares	50,000		50,000	D
Option to Purchase Common Shares	$3.15						(8)	06/30/2022	Common Shares	50,000		50,000	D

Explanation of Responses:

1. During October 2017, Mr. Kingsley gifted a total of 10,000 common shares.

2. Does not include shares that Mr. Kingsley may acquire through the exercise of certain options.

3. During December 2017, Greenbelt Corp. gifted a total of 100,000 common shares to certain charitable organizations.

4. 12,500 options became exercisable on September 30, 2013; December 31, 2013; March 31, 2014; and June 30, 2014.

5. 12,500 options became exercisable on September 30, 2014; December 31, 2014; March 31, 2015, and June 30, 2015.

6. 12,500 options became exercisable on September 30, 2015; December 31, 2015; March 31, 2016; and June 30, 2016.

7. 12,500 options became exercisable on September 30, 2016; December 31, 2016; March 31, 2017; and June 30, 2017.

8. 12,500 options became exercisable on September 30, 2017 and December 31, 2017, and the remaining 25,000 options will become exercisable in 2 equal quarterly installments based upon continued service on the board of directors.

Remarks:

Mr. Kingsley is Executive Chairman of certain BioTime subsidiaries.

	/s/ Alfred D. Kingsley	02/14/2018
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.